Use Of Chk2 Kinase Inhibitors For Cancer Treatment
Canada
2617150
Filed on 2008-01-27
2617150
Filed on 2008-01-27
Use Of Chk2 Kinase Inhibitors For Cancer Treatment
Australia
2006275679
Filed on 2006-07-27
2006275679
Filed on 2006-07-27
Topical Formulation Of Histone Deacetylase Inhibitors and Methods Using the Same
US Application 12/064,220
Filed on 2008-02-19
Filed on 2008-02-19
Topical Formulation of Histone Deacetylase Inhibitors and Methods of Using the Same
Japan
527070/2008
Filed on 2006-08-15
527070/2008
Filed on 2006-08-15
Topical Formulation of Histone Deacetylase Inhibitors and Methods of Using the Same
European Patent
06813470.9
Filed on 2006-08-15
06813470.9
Filed on 2006-08-15
Topical Formulations of Histone Deacetylase Inhibitors and Methods of Using the Same
Canada
2619568
Filed on 2006-08-15
2619568
Filed on 2006-08-15
Topical Formulation of Histone Deacetylase Inhibitors and Methods of Using the Same
Australia
2006283677
Filed on 2006-08-15
2006283677
Filed on 2006-08-15
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Turkey
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Slovakia
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Slovenia
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12